Why a lymphoma estimate is not a fixed total
Lymphoma is not one disease. Hodgkin and non-Hodgkin lymphoma differ, and the exact subtype guides which treatment is discussed. A hospital estimate is therefore built around a proposed plan for a specific diagnosis and stage, not a general lymphoma package. If the diagnosis changes after further pathology review, the plan and its cost scope can change with it.
An estimate is a written scope, not a guarantee. It may list the planned chemotherapy, radiotherapy or other treatment, the expected inpatient days, and named tests. Anything not written into that document is a question to ask, not an assumption. The hospital decides what it will authorise, and the treating clinician decides what is medically needed.
For an overseas patient, the practical risk is a gap between what you believed was covered and what the hospital later bills. That gap is usually closed by asking for the estimate in writing and requesting a clear included, excluded and undecided list before you commit to travel.
Items that may sit outside the initial estimate
Several categories commonly need separate confirmation. The first is diagnostic and staging work: pathology review, molecular or genomic testing, imaging such as PET-CT, and bone marrow studies. Some may be included in a treatment estimate; others may be quoted separately or ordered later.
The second is supportive care. Blood transfusions, growth factors, anti-nausea medicines, antibiotics, antivirals and antifungals can be needed during treatment. Whether these are bundled into a daily or cycle charge, or billed as separate items, depends on the hospital's own billing structure. Ask the named hospital how its written estimate treats them.
The third is unplanned care. Extra inpatient days, intensive care, treatment for infection or other complications, and changes to the regimen can all fall outside an initial estimate. These are not failures of planning; they are the reality of treating a condition whose course can vary.
The fourth is drug access and sourcing. Some lymphoma medicines may be available at a given hospital, some may need to be obtained elsewhere, and some may not be accessible at all. Do not assume that a drug named in a foreign guideline is available in China. Ask the hospital directly which medicines it can supply for your subtype and what the patient is expected to pay for.
The fifth is coordination and travel. Hospital fees, our coordination fees and travel costs are separate. Hospital consultations, tests, treatment, medicines and rooms are paid to the hospital or relevant provider. Our coordination fees are separate and are agreed in writing before work begins.
Records that support a meaningful review
A hospital cannot give a useful estimate without enough information. For lymphoma, the most important records are the pathology report and any molecular or genomic results that define the subtype. A biopsy report that says only "lymphoma" is not enough to plan treatment.
The second group is staging and response records. Imaging reports, bone marrow results and any PET-CT findings show how far the disease has spread and how it has responded to previous treatment. If you have already had treatment, the previous regimen, the number of cycles, the response and any toxicities matter.
The third group is your current clinical status. Recent blood counts, liver and kidney function, infection screening and a summary of other medical conditions help the treating team judge what monitoring or admission may be needed. Ask the hospital which specific documents it requires before it can review the next treatment step.
You do not need to send a complete archive at first contact. A brief summary is enough to start. After initial contact, we can explain how to share records securely. Do not send passport numbers, card details or a full medical file through an initial enquiry form.
What a records-based review can and cannot establish
A records-based review can help a hospital specialist understand your diagnosis, previous treatment and response, and indicate whether further assessment in China is worth considering. It can also identify missing information that would be needed before a treatment plan or estimate is prepared.
It cannot confirm hospital acceptance, guarantee a particular regimen, establish drug availability or predict how you will respond. Eligibility for a clinical trial, transplant or cellular therapy is a separate assessment and is never established by an initial review. A proxy consultation is optional and is not a prerequisite for every appointment or operation.
If you are currently receiving treatment, do not interrupt it for an overseas enquiry. Urgent or worsening symptoms need local care first. An overseas review is a planning step, not an emergency route.
A practical next step
Start with a short summary: the lymphoma subtype if known, previous regimens and response, your main question, and what you want to find out. Our team checks the available diagnosis and records, identifies missing information and suggests the relevant next step. This initial case review is free and is not a diagnosis or a promise of acceptance.
If you want to proceed, we can request a records-based opinion from a relevant hospital specialist, or coordinate a specialist appointment. The hospital then decides whether to offer an appointment, what further records it needs and what its written estimate covers. Ask the hospital directly about any item you cannot see in that estimate.
Before you send anything, decide what you actually need from the hospital. If your question is about cost scope, ask for the written estimate and the included, excluded and undecided lists. If your question is about whether further treatment is worth considering, ask which pathology and response records the specialist needs to review the next step. If your question is about admission or monitoring, ask what the hospital requires before it can confirm a bed or a schedule. These are different requests, and the hospital may route them to different offices.
When you write, keep the first message short and specific. State the diagnosis as it appears on the pathology report, the treatment already received, the response, and the single question you want answered. Attach nothing sensitive in the first message. After initial contact, we can explain how to share records securely. A clear question gets a clearer answer than a long history with no focus.
If the hospital replies with a figure, read it as a scope document rather than a final bill. Check whether it names the regimen, the number of cycles or fractions, the expected inpatient days, and the tests it includes. For anything absent, ask whether it is excluded, undecided, or simply not yet known. Ask who will decide if the plan changes and how you will be told before a new charge is incurred.
Keep every version of the estimate and every written reply. If the plan changes after further pathology review or a response assessment, ask for a revised scope rather than relying on an earlier document. A verbal assurance that something will be covered is not the same as an updated written estimate, and the written version is what you can check later.
If you are already in treatment elsewhere, do not pause it to pursue an overseas enquiry. Finish the current cycle as your local team advises, and use the overseas review as planning for a later decision. Worsening symptoms need local assessment first, not an email.
For more on how lymphoma care is planned in China, see the lymphoma treatment reference.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.